Difference between revisions of "Template:Antithrombotics"

From blackwiki
Jump to navigation Jump to search
blackwiki>Arcadian
(navs)
blackwiki>Anypodetos
(Classifies and sorted antiplatelet drugs; added Terutroban and Cilostazol; copyedit)
Line 11: Line 11:
 
|  list1 = [[Abciximab]]{{•}} [[Eptifibatide]]{{•}} [[Tirofiban]]
 
|  list1 = [[Abciximab]]{{•}} [[Eptifibatide]]{{•}} [[Tirofiban]]
  
| group2 = [[ADP receptor]]/[[P2Y12|P2Y<sub>12</sub>]] inhibitors
+
| group2 = [[P2Y12|ADP receptor/P2Y<sub>12</sub>]] inhibitors
|  list2 = ''[[thienopyridine]]s'' ([[Clopidogrel]]{{•}} [[Prasugrel]]{{•}} [[Ticlopidine]]){{•}} [[Ticagrelor]]<sup>†</sup>
+
|  list2 = ''[[thienopyridine]]s'' ([[Clopidogrel]], [[Prasugrel]], [[Ticlopidine]]){{•}} [[Ticagrelor]]<sup>†</sup>
  
 
| group3 = [[Prostaglandin analogue]] ([[Prostacyclin|PGI2]])
 
| group3 = [[Prostaglandin analogue]] ([[Prostacyclin|PGI2]])
Line 18: Line 18:
  
 
| group4 = [[Mechanism of action of aspirin|COX inhibitors]]
 
| group4 = [[Mechanism of action of aspirin|COX inhibitors]]
|  list4 = [[Aspirin|Acetylsalicylic acid/Aspirin]]&nbsp;#{{•}} [[Aloxiprin]]{{•}} [[Carbasalate calcium]]
+
|  list4 = [[Aspirin|Acetylsalicylic acid/Aspirin]]<sup>#</sup>{{•}} [[Aloxiprin]]{{•}} [[Carbasalate calcium]]{{•}} [[Indobufen]]{{•}} [[Triflusal]]
  
| group5 = Other
+
| group5 = [[Thromboxane]] inhibitors
|  list5 = [[Ditazole]]{{•}} [[Cloricromen]]{{•}} [[Dipyridamole]]{{•}} [[Indobufen]]{{•}} [[Picotamide]]{{•}} [[Triflusal]]
+
|  list5 = ''[[thromboxane synthase]] inhibitors'' ([[Dipyridamole]], [[Picotamide]]){{•}} ''[[Thromboxane receptor antagonist|receptor antagonist]]'' ([[Terutroban]]<sup>†</sup>)
 +
 
 +
| group6 = [[Phosphodiesterase inhibitor]]s
 +
|  list6 = [[Cilostazol]]{{•}} [[Dipyridamole]]{{•}} [[Triflusal]]
 +
 
 +
| group7 = Other
 +
|  list7 = [[Cloricromen]]{{•}} [[Ditazole]]
  
 
}}
 
}}
Line 29: Line 35:
 
   | groupstyle = background-color: MistyRose
 
   | groupstyle = background-color: MistyRose
  
   | group1 = [[Vitamin K antagonist]]s<BR>(inhibit [[Thrombin|II]], [[Factor VII|VII]], [[Factor IX|IX]], [[Factor X|X]])
+
   | group1 = [[Vitamin K antagonist]]s<br />(inhibit [[Thrombin|II]], [[Factor VII|VII]], [[Factor IX|IX]], [[Factor X|X]])
   |  list1 = ''[[coumarin]]s:'' [[Acenocoumarol]]{{•}} [[Coumatetralyl]]{{•}} [[Dicoumarol]] (Dicumarol){{•}} [[Ethyl biscoumacetate]]{{•}} [[Phenprocoumon]]{{•}} [[Warfarin]]
+
   |  list1 = ''[[coumarin]]s:'' [[Acenocoumarol]]{{•}} [[Coumatetralyl]]{{•}} [[Dicoumarol]]{{•}} [[Ethyl biscoumacetate]]{{•}} [[Phenprocoumon]]{{•}} [[Warfarin]]
  
 
''[[1,3-Indandione]]s:'' [[Clorindione]]{{•}} [[Diphenadione]]{{•}} [[Phenindione]]
 
''[[1,3-Indandione]]s:'' [[Clorindione]]{{•}} [[Diphenadione]]{{•}} [[Phenindione]]
Line 36: Line 42:
 
''other:'' [[Tioclomarol]]  
 
''other:'' [[Tioclomarol]]  
  
| group2 = [[Factor Xa]] inhibitors<BR>(with some II inhibition)
+
| group2 = [[Factor Xa]] inhibitors<br />(with some II inhibition)
 
|  list2 = {{Navbox subgroup
 
|  list2 = {{Navbox subgroup
 
   | groupstyle = background-color: MistyRose
 
   | groupstyle = background-color: MistyRose
  
| group1 = [[Heparin]] group/<BR>[[glycosaminoglycan]]s/<BR>(bind [[antithrombin]])
+
| group1 = [[Heparin]] group/<br />[[glycosaminoglycan]]s/<br />(bind [[antithrombin]])
 
| list1  = ''[[low molecular weight heparin]]'' ([[Bemiparin]], [[Certoparin]], [[Dalteparin]], [[Enoxaparin sodium|Enoxaparin]], [[Nadroparin]], [[Parnaparin]], [[Reviparin]], [[Tinzaparin]])
 
| list1  = ''[[low molecular weight heparin]]'' ([[Bemiparin]], [[Certoparin]], [[Dalteparin]], [[Enoxaparin sodium|Enoxaparin]], [[Nadroparin]], [[Parnaparin]], [[Reviparin]], [[Tinzaparin]])
  
Line 53: Line 59:
  
 
| group6 = [[Direct thrombin inhibitor|Direct thrombin (II) inhibitor]]s
 
| group6 = [[Direct thrombin inhibitor|Direct thrombin (II) inhibitor]]s
|  list6 = ''[[Direct_thrombin_inhibitor#Bivalent|bivalent]]:'' [[Hirudin]] ([[Bivalirudin]], [[Lepirudin]], [[Desirudin]])<BR>
+
|  list6 = ''[[Direct_thrombin_inhibitor#Bivalent|bivalent]]:'' [[Hirudin]] ([[Bivalirudin]], [[Lepirudin]], [[Desirudin]])<br />
 
 
''[[Direct_thrombin_inhibitor#Univalent|univalent]]:'' [[Argatroban]]{{•}} [[Dabigatran]]{{•}} [[Melagatran]]‡{{•}} [[Ximelagatran]]‡
 
  
 +
''[[Direct_thrombin_inhibitor#Univalent|univalent]]:'' [[Argatroban]]{{•}} [[Dabigatran]]{{•}} [[Melagatran]]<sup>‡</sup>{{•}} [[Ximelagatran]]<sup>‡</sup>
  
 
| group8 = Other  
 
| group8 = Other  
Line 63: Line 68:
 
}}
 
}}
  
| group5 = [[Thrombolytic drug]]s/<BR>[[fibrinolytic]]s
+
| group5 = [[Thrombolytic drug]]s/<br />[[fibrinolytic]]s
|  list5 = ''[[plasminogen activator]]s:'' ''TPA'' ([[Tissue plasminogen activator|Alteplase]], [[Reteplase]], [[Tenecteplase]]){{•}} ''UPA'' ([[Urokinase]], [[Saruplase]]){{•}} [[Streptokinase]]&nbsp;#{{•}} [[Anistreplase]]{{•}} [[Monteplase]]
+
|  list5 = ''[[plasminogen activator]]s:'' ''TPA'' ([[Tissue plasminogen activator|Alteplase]], [[Reteplase]], [[Tenecteplase]]){{•}} ''UPA'' ([[Urokinase]], [[Saruplase]]){{•}} [[Streptokinase]]<sup>#</sup>{{•}} [[Anistreplase]]{{•}} [[Monteplase]]
  
 
''other [[serine endopeptidase]]s:'' [[Ancrod]]{{•}} [[Fibrinolysin]]
 
''other [[serine endopeptidase]]s:'' [[Ancrod]]{{•}} [[Fibrinolysin]]

Revision as of 17:21, 5 April 2010